Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
复制标题
DOI：
10.1016/j.ejca.2010.02.015
复制
发表时间：
2010-05-01
影响因子：
8.4
通讯作者：
Wilson, Robin
中科院分区：
文献类型：
--
作者：
Sardanelli, Francesco;Boetes, Carla;Wilson, Robin
乳腺磁共振成像(MRI)的使用正在迅速增加。2008年10月20-21日，EUSOMA在米兰组织了一次研讨会，以评估目前关于乳腺MRI的临床价值和适应症的证据。来自涉及乳腺疾病管理的学科的23名专家--包括流行病学家、遗传学家、肿瘤学家、放射科医生、放射肿瘤学家和外科医生--在全体会议和重点会议上讨论了使用这项技术的证据。本文件介绍了该工作组达成的共识。首先考虑了一般性建议、技术要求、方法和解释。对于以下十种适应症，定义了证据概述、建议清单和一些研究问题：治疗计划前的分期；高危女性的筛查；新辅助化疗的反应评估；隆胸或再造患者；隐匿性原发乳腺癌；乳腺癌复发；乳头溢液；常规影像中可疑发现的特征；炎性乳腺癌；以及男性乳房。工作组强烈建议所有乳腺癌专家合作，使这项新兴技术在临床上得到最佳利用，并在未来的研究中将重点放在作为主要终点的患者结果上。(C)2010爱思唯尔有限公司。保留所有权利。
The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA organised a workshop in Milan on 20-21st October 2008 to evaluate the evidence currently available on clinical value and indications for breast MRI. Twenty-three experts from the disciplines involved in breast disease management - including epidemiologists, geneticists, oncologists, radiologists, radiation oncologists, and surgeons - discussed the evidence for the use of this technology in plenary and focused sessions. This paper presents the consensus reached by this working group. General recommendations, technical requirements, methodology, and interpretation were firstly considered. For the following ten indications, an overview of the evidence, a list of recommendations, and a number of research issues were defined: staging before treatment planning; screening of high-risk women; evaluation of response to neoadjuvant chemotherapy; patients with breast augmentation or reconstruction; occult primary breast cancer; breast cancer recurrence; nipple discharge; characterisation of equivocal findings at conventional imaging; inflammatory breast cancer; and male breast. The working group strongly suggests that all breast cancer specialists cooperate for an optimal clinical use of this emerging technology and for future research, focusing on patient outcome as primary end-point. (C) 2010 Elsevier Ltd. All rights reserved.